{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:31:48Z","timestamp":1791851508168,"version":"4.3.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00415-018-8751-9","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T05:34:06Z","timestamp":1516858446000},"page":"1251-1258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Myasthenia gravis and infectious disease"],"prefix":"10.1007","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6522-5102","authenticated-orcid":false,"given":"Nils Erik","family":"Gilhus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Romi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir Olve","family":"Skeie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"key":"8751_CR1","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.dld.2017.09.002","volume":"49","author":"C Abreu","year":"2017","unstructured":"Abreu C, Sarmento A, Magro F (2017) Screening, prophylaxis and counselling before the start of biological therapies: a practical approach focused on IBD patients. Dig Liver Dis 49:1289\u20131297","journal-title":"Dig Liver Dis"},{"key":"8751_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/ane.12233","volume":"129","author":"JB Andersen","year":"2014","unstructured":"Andersen JB, Heldal AT, Engeland A, Gilhus NE (2014) Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurol Scand 129:26\u201331","journal-title":"Acta Neurol Scand"},{"key":"8751_CR3","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/ene.12439","volume":"21","author":"JB Andersen","year":"2014","unstructured":"Andersen JB, Owe JF, Engeland A, Gilhus NE (2014) Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study. Eur J Neurol 21:948\u2013955","journal-title":"Eur J Neurol"},{"key":"8751_CR4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/mus.22077","volume":"43","author":"E Auriel","year":"2011","unstructured":"Auriel E, Regev K, Dori A, Karni A (2011) Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance. Muscle Nerve 43:893\u2013894","journal-title":"Muscle Nerve"},{"key":"8751_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1749-6632.2012.06774.x","volume":"1274","author":"JF Bach","year":"2012","unstructured":"Bach JF (2012) The etiology of autoimmune diseases: the case of myasthenia gravis. Annals N Y Acad Sci 1274:33\u201339","journal-title":"Annals N Y Acad Sci"},{"key":"8751_CR6","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.imbio.2016.06.012","volume":"221","author":"C Barzago","year":"2016","unstructured":"Barzago C, Lum J, Cavalcante P, Srinivasan KG, Faggiani E, Camera G, Bonanno S, Andreetta F, Antozzi C, Baggi F, Calogero RA, Bernasconi P, Mantegazza R, Mori L, Zolezzi F (2016) A novel infection- and inflammation(_)associated molecular signature in peripheral blood of myasthenia gravis patients. Immunobiology 221:1227\u20131236","journal-title":"Immunobiology"},{"key":"8751_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","volume":"52","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90\u2013100","journal-title":"J Autoimmun"},{"key":"8751_CR8","doi-asserted-by":"crossref","unstructured":"Bhattacharyya S, Darby R, Berkowitz AL (2014) Antibiotic-induced neurotoxicity. Current infectious disease reports 16","DOI":"10.1007\/s11908-014-0448-3"},{"key":"8751_CR9","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jocn.2015.01.022","volume":"22","author":"S Blum","year":"2015","unstructured":"Blum S, Lee D, Gillis D, McEniery DF, Reddel S, McCombe P (2015) Clinical features and impact of myasthenia gravis disease in Australian patients. J Clin Neurosci 22:1164\u20131169","journal-title":"J Clin Neurosci"},{"key":"8751_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/MCP.0000000000000426","volume":"23","author":"M Bonvalet","year":"2017","unstructured":"Bonvalet M, Ollila HM, Ambati A, Mignot E (2017) Autoimmunity in narcolepsy. Curr Opin Pulm Med 23:522\u2013529","journal-title":"Curr Opin Pulm Med"},{"key":"8751_CR11","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/ard.2010.144998","volume":"70","author":"MH Buch","year":"2011","unstructured":"Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dorner T, Ferraccioli G, Gottenberg JE, Isaacs J, Kvien TK, Mariette X, Martin-Mola E, Pavelka K, Tak PP, van der Heijde D, van Vollenhoven RF, Emery P, Rituximab Consensus Expert C (2011) Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 70:909\u2013920","journal-title":"Ann Rheum Dis"},{"key":"8751_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.imbio.2015.12.007","volume":"221","author":"P Cavalcante","year":"2016","unstructured":"Cavalcante P, Galbardi B, Franzi S, Marcuzzo S, Barzago C, Bonanno S, Camera G, Maggi L, Kapetis D, Andreetta F, Biasiucci A, Motta T, Giardina C, Antozzi C, Baggi F, Mantegazza R, Bernasconi P (2016) Increased expression of toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein\u2013Barr virus infection. Immunobiology 221:516\u2013527","journal-title":"Immunobiology"},{"key":"8751_CR13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","volume":"67","author":"P Cavalcante","year":"2010","unstructured":"Cavalcante P, Serafini B, Rosicarelli B, Maggi L, Barberis M, Antozzi C, Berrih-Aknin S, Bernasconi P, Aloisi F, Mantegazza R (2010) Epstein\u2013Barr virus persistence and reactivation in myasthenia gravis thymus. Ann Neurol 67:726\u2013738","journal-title":"Ann Neurol"},{"key":"8751_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s13365-014-0303-1","volume":"21","author":"S Chahin","year":"2015","unstructured":"Chahin S, Berger JR (2015) A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy. J Neurovirol 21:623\u2013631","journal-title":"J Neurovirol"},{"key":"8751_CR15","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1080\/14760584.2016.1193438","volume":"15","author":"DR Cheng","year":"2016","unstructured":"Cheng DR, Barton R, Greenway A, Crawford NW (2016) Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients. Expert Rev Vaccines 15:1567\u20131574","journal-title":"Expert Rev Vaccines"},{"key":"8751_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1615\/CritRevImmunol.2017018916","volume":"36","author":"P Christopoulos","year":"2016","unstructured":"Christopoulos P, Fisch P (2016) Acquired T-cell immunodeficiency in thymoma patients. Crit Rev Immunol 36:315\u2013327","journal-title":"Crit Rev Immunol"},{"key":"8751_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.molimm.2013.01.012","volume":"54","author":"D Csuka","year":"2013","unstructured":"Csuka D, Czirjak L, Hobor R, Illes Z, Banati M, Rajczy K, Tordai A, Fust G (2013) Effective humoral immunity against diphtheria and tetanus in patients with systemic lupus erythematosus or myasthenia gravis. Mol Immunol 54:453\u2013456","journal-title":"Mol Immunol"},{"key":"8751_CR18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1136\/ard.2010.144741","volume":"70","author":"WG Dixon","year":"2011","unstructured":"Dixon WG, Kezouh A, Bernatsky S, Suissa S (2011) The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case\u2013control study. Ann Rheum Dis 70:956\u2013960","journal-title":"Ann Rheum Dis"},{"key":"8751_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1023\/A:1026683007277","volume":"44","author":"S Eddy","year":"1999","unstructured":"Eddy S, Wim R, Peter V, Tanja R, Jan T, Werner V (1999) Myasthenia gravis\u2014another autoimmune disease associated with hepatitis C virus infection. Dig Dis Sci 44:186\u2013189","journal-title":"Dig Dis Sci"},{"issue":"5","key":"8751_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002024","volume":"13","author":"L Fardet","year":"2016","unstructured":"Fardet L, Petersen I, Nazareth I (2016) Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. Plos Med 13(5):e1002024. https:\/\/doi.org\/10.1371\/journal.pmed.1002024","journal-title":"Plos Med"},{"key":"8751_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/art.39849","volume":"69","author":"CH Feldman","year":"2017","unstructured":"Feldman CH, Marty FM, Winkelmayer WC, Guan HS, Franklin JM, Solomon DH, Costenbader KH, Kim SC (2017) Comparative rates of serious infections among patients with systemic lupus erythematosus receiving immunosuppressive medications. Arthritis Rheumatol 69:387\u2013397","journal-title":"Arthritis Rheumatol"},{"key":"8751_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/BOR.0000000000000281","volume":"28","author":"MA Friedman","year":"2016","unstructured":"Friedman MA, Winthrop K (2016) Vaccinations for rheumatoid arthritis. Curr Opin Rheumatol 28:330\u2013336","journal-title":"Curr Opin Rheumatol"},{"key":"8751_CR23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S1474-4422(17)30363-0","volume":"16","author":"NE Gilhus","year":"2017","unstructured":"Gilhus NE (2017) Eculizumab: a treatment option for mysthenia gravis? Lancet Neurol 16:947\u2013948","journal-title":"Lancet Neurol"},{"key":"8751_CR24","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE (2016) Myasthenia gravis. N Engl J Med 375:2570\u20132581","journal-title":"N Engl J Med"},{"key":"8751_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ene.12599","volume":"22","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Nacu A, Andersen JB, Owe JF (2015) Myasthenia gravis and risks for comorbidity. Eur J Neurol 22:17\u201323","journal-title":"Eur J Neurol"},{"key":"8751_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023\u20131036","journal-title":"Lancet Neurol"},{"key":"8751_CR27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00415-015-7638-2","volume":"262","author":"MC Gui","year":"2015","unstructured":"Gui MC, Luo X, Lin J, Li Y, Zhang M, Zhang XF, Yang MS, Wang W, Bu BT (2015) Long-term outcome of 424 childhood-onset myasthenia gravis patients. J Neurol 262:823\u2013830","journal-title":"J Neurol"},{"key":"8751_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/08916934.2016.1214823","volume":"49","author":"JT Guptill","year":"2016","unstructured":"Guptill JT, Juel VC, Massey JM, Anderson AC, Chopra M, Yi JS, Esfandiari E, Buchanan T, Smith B, Atherfold P, Jones E, Howard JF (2016) Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis. Autoimmunity 49:472\u2013479","journal-title":"Autoimmunity"},{"key":"8751_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.humimm.2011.12.022","volume":"73","author":"A Holbro","year":"2012","unstructured":"Holbro A, Jauch A, Lardinois D, Tzankov A, Dirnhofer S, Hess C (2012) High prevalence of infections and autoimmunity in patients with thymoma. Hum Immunol 73:287\u2013290","journal-title":"Hum Immunol"},{"key":"8751_CR30","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.clineuro.2011.03.019","volume":"113","author":"WL Hung","year":"2011","unstructured":"Hung WL, Lin YH, Wang PY, Chang MH (2011) HIV-associated myasthenia gravis and impacts of HAART: one case report and a brief review. Clin Neurol Neurosurg 113:672\u2013674","journal-title":"Clin Neurol Neurosurg"},{"key":"8751_CR31","first-page":"1","volume":"111","author":"B Jf","year":"2017","unstructured":"Jf B (2017) The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol 111:1\u201316","journal-title":"Nat Rev Immunol"},{"key":"8751_CR32","first-page":"345","volume":"128","author":"F Jing","year":"2013","unstructured":"Jing F, Wei D, Wang D, Li N, Cui F, Yang F, Chen Z, Huang X (2013) Lack of Epstein\u2013Barr virus infection in Chinese myasthenia gravis patients. Acta Neurol Scand 128:345\u2013350","journal-title":"Acta Neurol Scand"},{"key":"8751_CR33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2165\/11593110-000000000-00000","volume":"34","author":"SC Jones","year":"2011","unstructured":"Jones SC, Sorbello A, Boucher RM (2011) Fluoroquinolone-associated myasthenia gravis exacerbation evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review. Drug Saf 34:839\u2013847","journal-title":"Drug Saf"},{"key":"8751_CR34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ana.22488","volume":"70","author":"K Kakalacheva","year":"2011","unstructured":"Kakalacheva K, Maurer MA, Tackenberg B, Munz C, Willcox N, Lunemann JD (2011) Intrathymic Epstein\u2013Barr virus infection is not a prominent feature of myasthenia gravis. Ann Neurol 70:508\u2013514","journal-title":"Ann Neurol"},{"key":"8751_CR35","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10072-014-1659-y","volume":"35","author":"J Kalita","year":"2014","unstructured":"Kalita J, Kohat AK, Misra UK (2014) Predictors of outcome of myasthenic crisis. Neurol Sci 35:1109\u20131114","journal-title":"Neurol Sci"},{"key":"8751_CR36","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.1212\/CPJ.0000000000000202","volume":"6","author":"KM Kanth","year":"2016","unstructured":"Kanth KM, Solorzano GE, Goldman MD (2016) PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents. Neurol Clin Pract 6:E17\u2013E19","journal-title":"Neurol Clin Pract"},{"key":"8751_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clim.2017.07.001","volume":"183","author":"HL Kohling","year":"2017","unstructured":"Kohling HL, Plummer SF, Marchesi JR, Davidge KS, Ludgate M (2017) The microbiota and autoimmunity: their role in thyroid autoimmune diseases. Clin Immunol 183:63\u201374","journal-title":"Clin Immunol"},{"key":"8751_CR38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.amepre.2017.08.029","volume":"53","author":"P Le","year":"2017","unstructured":"Le P, Rothberg MB (2017) Cost effectiveness of a shingles vaccine booster for currently vaccinated adults in the US. Am J Prev Med 53:829\u2013836","journal-title":"Am J Prev Med"},{"key":"8751_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/mus.23869","volume":"49","author":"AA Leis","year":"2014","unstructured":"Leis AA, Szatmary G, Ross MA, Stokic DS (2014) West nile virus infection and myasthenia gravis. Muscle Nerve 49:26\u201329","journal-title":"Muscle Nerve"},{"key":"8751_CR40","doi-asserted-by":"publisher","first-page":"9726","DOI":"10.1074\/jbc.M110.170993","volume":"286","author":"IJ Liu","year":"2011","unstructured":"Liu IJ, Chiu CY, Chen YC, Wu HC (2011) Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem 286:9726\u20139736","journal-title":"J Biol Chem"},{"key":"8751_CR41","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1186\/s12879-016-2084-z","volume":"16","author":"XQ Liu","year":"2016","unstructured":"Liu XQ, Bian SN, Zhang YQ, Zhang LF, Yang QW, Wang P, Xu YC, Shi XC, Zhang Y, Chemaly RF (2016) The characteristics of patients with Mycobacterium tuberculosis blood stream infections in Beijing, China: a retrospective study. BMC Infect Dis 16:750. https:\/\/doi.org\/10.1186\/s12879-016-2084-z","journal-title":"BMC Infect Dis"},{"key":"8751_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.7326\/M16-2733","volume":"167","author":"GK Ma","year":"2017","unstructured":"Ma GK, Brensinger CM, Wu QF, Lewis JD (2017) Increasing incidence of multiply recurrent Clostridium difficile infection in the United States a cohort study. Ann Intern Med 167:152\u2013158","journal-title":"Ann Intern Med"},{"key":"8751_CR43","doi-asserted-by":"publisher","unstructured":"Maniaol AH, Elsais A, Lorentzen AR, Owe JF, Viken MK, Saether H, Flam ST, Brathen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CME, Lie BA, Harbo HF (2012) Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population. Plos One 7(5):e36603. https:\/\/doi.org\/10.1371\/journal.pone.0036603","DOI":"10.1371\/journal.pone.0036603"},{"key":"8751_CR44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875\u2013884","journal-title":"Autoimmun Rev"},{"issue":"Suppl 6","key":"8751_CR45","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2105-15-S6-S3","volume":"15","author":"RD Melamed","year":"2014","unstructured":"Melamed RD, Khiabanian H, Rabadan R (2014) Data-driven discovery of seasonally linked diseases from an electronic health records system. BMC Bioinf 15 (Suppl 6):S3. https:\/\/doi.org\/10.1186\/1471-2105-15-S6-S3","journal-title":"BMC Bioinf"},{"key":"8751_CR46","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.autrev.2010.03.004","volume":"10","author":"A Meyer","year":"2011","unstructured":"Meyer A, Levy Y (2011) Geoepidemiology of myasthenia gravis (vol 9, pg A383, 2010). Autoimmun Rev 10:811","journal-title":"Autoimmun Rev"},{"key":"8751_CR47","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/ana.22522","volume":"70","author":"M Meyer","year":"2011","unstructured":"Meyer M, Hols AK, Liersch B, Leistner R, Gellert K, Schalke B, Marx A, Niedobitek G (2011) Lack of evidence for Epstein\u2013Barr virus infection in myasthenia gravis thymus. Ann Neurol 70:515\u2013518","journal-title":"Ann Neurol"},{"key":"8751_CR48","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1212\/WNL.0000000000003697","volume":"88","author":"N Molko","year":"2017","unstructured":"Molko N, Simon O, Guyon D, Biron A, Dupont-Rouzeyrol M, Gourinat AC (2017) Zika virus infection and myasthenia gravis: report of 2 cases. Neurology 88:1097\u20131098","journal-title":"Neurology"},{"key":"8751_CR49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4049\/jimmunol.1700178","volume":"199","author":"E Morandi","year":"2017","unstructured":"Morandi E, Jagessar SA, A\u2018t Hart B, Gran B (2017) EBV infection empowers human B cells for Autoimmunity: role of autophagy and relevance to multiple sclerosis. J Immunol 199:435\u2013448","journal-title":"J Immunol"},{"key":"8751_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nri2527","volume":"9","author":"C Munz","year":"2009","unstructured":"Munz C, Lunemann JD, Getts MT, Miller SD (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9:246\u2013258","journal-title":"Nat Rev Immunol"},{"key":"8751_CR51","doi-asserted-by":"crossref","unstructured":"Niller HH, Wolf H, Ay E, Minarovits J (2011) Epigenetic dysregulation of Epstein\u2013Barr virus latency and development of autoimmune disease. Adv Exp Med Biol 711:82\u2013102","DOI":"10.1007\/978-1-4419-8216-2_7"},{"key":"8751_CR52","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/jpids\/pix066","volume":"6","author":"ST O\u2019Leary","year":"2017","unstructured":"O\u2019Leary ST, Kimberlin DW (2017) Update from the advisory committee on immunization practices. J Pediatr Infect Dis Soc 6:311\u2013316","journal-title":"J Pediatr Infect Dis Soc"},{"key":"8751_CR53","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/ajg.2017.180","volume":"112","author":"I Ordas","year":"2017","unstructured":"Ordas I, Domenech E, Manosa M, Garcia-Sanchez V, Iglesias-Flores E, Penalva M, Canas-Ventura A, Merino O, Fernandez-Banares F, Gomollon F, Vera M, Gutierrez A, Garcia-Planella E, Chaparro M, Aguas M, Gento E, Munoz F, Aguirresarobe M, Munoz C, Fernandez L, Calvet X, Jimenez CE, Montoro MA, Mir A, De Castro ML, Garcia-Sepulcre MF, Bermejo F, Panes J, Esteve M, GETECCU ER (2017) Long-term efficacy and safety of cyclosporine in a cohort of steroid-refractory acute severe ulcerative colitis patients from the ENEIDA registry (1989\u20132013): a nationwide multicenter study. Am J Gastroenterol 112:1709\u20131718","journal-title":"Am J Gastroenterol"},{"key":"8751_CR54","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1212\/01.wnl.0000247741.72466.8c","volume":"67","author":"X Perrot","year":"2006","unstructured":"Perrot X, Bernard N, Vial C, Antoine JC, Laurent H, Vial T, Confavreux C, Vukusic S (2006) Myasthenia gravis exacerbation or unmasking associated with telithromycin treatment. Neurology 67:2256\u20132258","journal-title":"Neurology"},{"key":"8751_CR55","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jcv.2013.08.035","volume":"58","author":"M Prelog","year":"2013","unstructured":"Prelog M, Egli A, Zlamy M, Hirsch HH (2013) JC and BK polyomavirus-specific immunoglobulin G responses in patients thymectomized in early childhood. J Clin Virol 58:553\u2013558","journal-title":"J Clin Virol"},{"key":"8751_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1741-7015-11-97","volume":"11","author":"SV Ramagopalan","year":"2013","unstructured":"Ramagopalan SV, Goldacre R, Skingsley A, Conlon C, Goldacre MJ (2013) Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies. BMC Med 11:97. https:\/\/doi.org\/10.1186\/1741-7015-11-97","journal-title":"BMC Med"},{"key":"8751_CR57","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/ene.12703","volume":"22","author":"A Ramos-Fransi","year":"2015","unstructured":"Ramos-Fransi A, Rojas-Garcia R, Segovia S, Marquez-Infante C, Pardo J, Coll-Canti J, Jerico I, Illa I, Myasthenia NMDESSG (2015) Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry. Eur J Neurol 22:1056\u20131061","journal-title":"Eur J Neurol"},{"key":"8751_CR58","doi-asserted-by":"publisher","first-page":"131","DOI":"10.18773\/austprescr.2016.053","volume":"39","author":"KL Randall","year":"2016","unstructured":"Randall KL (2016) Rituximab in autoimmune diseases. Aust Prescr 39:131\u2013134","journal-title":"Aust Prescr"},{"key":"8751_CR59","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","volume":"72","author":"AE Renton","year":"2015","unstructured":"Renton AE, Pliner HA, Provenzano C, Evoli A, Ricciardi R, Nalls MA, Marangi G, Abramzon Y, Arepalli S, Chong S, Hernandez DG, Johnson JO, Bartoccioni E, Scuderi F, Maestri M, Gibbs JR, Errichiello E, Chio A, Restagno G, Sabatelli M, Macek M, Scholz SW, Corse A, Chaudhry V, Benatar M, Barohn RJ, McVey A, Pasnoor M, Dimachkie MM, Rowin J, Kissel J, Freimer M, Kaminski HJ, Sanders DB, Lipscomb B, Massey JM, Chopra M, Howard JF, Koopman WJ, Nicolle MW, Pascuzzi RM, Pestronk A, Wulf C, Florence J, Blackmore D, Soloway A, Siddiqi Z, Muppidi S, Wolfe G, Richman D, Mezei MM, Jiwa T, Oger J, Drachman DB, Traynor BJ (2015) A genome-wide association study of myasthenia gravis. JAMA Neurol 72:396\u2013404","journal-title":"JAMA Neurol"},{"key":"8751_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0165-5728(02)00145-5","volume":"128","author":"F Romi","year":"2002","unstructured":"Romi F, Bo L, Skeie GO, Myking A, Aarli JA, Gilhus NE (2002) Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol 128:82\u201389","journal-title":"J Neuroimmunol"},{"key":"8751_CR61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coi.2017.07.006","volume":"49","author":"F Romi","year":"2017","unstructured":"Romi F, Hong Y, Gilhus NE (2017) Pathophysiology and immunological profile of myasthenia gravis and its subgroups. Curr Opin immunol 49:9\u201313","journal-title":"Curr Opin immunol"},{"issue":"5","key":"8751_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002025","volume":"13","author":"L Rostaing","year":"2016","unstructured":"Rostaing L, Malvezzi P (2016) Steroid-based therapy and risk of infectious complications. Plos Med 13(5):e1002025. https:\/\/doi.org\/10.1371\/journal.pmed.1002025","journal-title":"Plos Med"},{"key":"8751_CR63","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/08830185.2010.483028","volume":"29","author":"S Salemi","year":"2010","unstructured":"Salemi S, D\u2019Amelio R (2010) Are anti-infectious vaccinations safe and effective in patients with autoimmunity? Int Rev Immunol 29:270\u2013314","journal-title":"Int Rev Immunol"},{"key":"8751_CR64","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1016\/j.vaccine.2017.08.065","volume":"35","author":"SAJ Schmidt","year":"2017","unstructured":"Schmidt SAJ, Vestergaard M, Baggesen LM, Pedersen L, Schonheyder HC, Sorensen HT (2017) Prevaccination epidemiology of herpes zoster in Denmark: quantification of occurrence and risk factors. Vaccine 35:5589\u20135596","journal-title":"Vaccine"},{"key":"8751_CR65","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.4049\/jimmunol.166.4.2808","volume":"166","author":"GD Sempowski","year":"2001","unstructured":"Sempowski GD, Thomasch JR, Gooding ME, Hale LP, Edwards LJ, Ciafaloni E, Sanders DB, Massey JM, Douek DC, Koup RA, Haynes BF (2001) Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis. J Immunol 166:2808\u20132817","journal-title":"J Immunol"},{"key":"8751_CR66","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3988\/jcn.2017.13.4.325","volume":"13","author":"HY Seok","year":"2017","unstructured":"Seok HY, Shin HY, Kim JK, Kim BJ, Oh J, Suh BC, Kim SY, Kang SY, Ahn SW, Bae JS, Kim BJ (2017) The impacts of influenza infection and vaccination on exacerbation of myasthenia gravis. J Clin Neurol 13:325\u2013330","journal-title":"J Clin Neurol"},{"key":"8751_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005590.pub3","volume":"10","author":"A Stern","year":"2014","unstructured":"Stern A, Green H, Paul M, Vidal L, Leibovici L (2014) Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 10:CD005590. https:\/\/doi.org\/10.1002\/14651858.CD005590.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"8751_CR68","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1016\/j.vaccine.2017.10.017","volume":"35","author":"A Strezova","year":"2017","unstructured":"Strezova A, Godeaux O, Aggarwal N, Leroux-Roels G, Lopez-Fauqued M, Van Damme P, Vanden Abeele C, Vastiau I, Heineman TC, Lal H (2017) A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ\/su. Vaccine 35:6700\u20136706","journal-title":"Vaccine"},{"key":"8751_CR69","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.1016\/j.vaccine.2017.09.078","volume":"35","author":"E Strijbos","year":"2017","unstructured":"Strijbos E, Huijbers MG, van Es IE, Alleman I, van Ostaijen-ten Dam MM, Bakker J, van Zwet EW, Jol-van der Zijde CM, van Tol MD, Verschuuren JJ (2017) A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis. Vaccine 35:6290\u20136296","journal-title":"Vaccine"},{"key":"8751_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2010.02.016","volume":"292","author":"JP Stubgen","year":"2010","unstructured":"Stubgen JP (2010) Neuromuscular disorders associated with Hepatitis B vaccination. J Neurol Sci 292:1\u20134","journal-title":"J Neurol Sci"},{"key":"8751_CR71","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00296-017-3811-5","volume":"37","author":"N Sugimoto","year":"2017","unstructured":"Sugimoto N, Nakajima A, Inoue E, Shidara K, Yamashita H, Mimori A, Tokuda H, Seto Y, Tanaka E, Momohara S, Taniguchi A, Yamanaka H (2017) Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis. Rheumatol Int 37:1871\u20131878","journal-title":"Rheumatol Int"},{"key":"8751_CR72","first-page":"461","volume":"10","author":"C Trivin","year":"2017","unstructured":"Trivin C, Tran A, Moulin B, Choukroun G, Gatault P, Courivaud C, Augusto JF, Ficheux M, Vigneau C, Thervet E, Karras A (2017) Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease. Clin Kidney J 10:461\u2013469","journal-title":"Clin Kidney J"},{"key":"8751_CR73","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jemermed.2015.04.019","volume":"50","author":"MA Berkel Van","year":"2016","unstructured":"Van Berkel MA, Twilla JD, England BS (2016) Emergency department management of a myasthenia gravis patient with community-acquired pneumonia: does initial antibiotic choice lead to cure or crisis? J Emerg Med 50:281\u2013285","journal-title":"J Emerg Med"},{"issue":"4","key":"8751_CR74","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005769","volume":"96","author":"E Virot","year":"2017","unstructured":"Virot E, Duclos A, Adelaide L, Miailhes P, Hot A, Ferry T, Seve P (2017) Autoimmune diseases and HIV infection a cross-sectional study. Med 96(4):e5769. https:\/\/doi.org\/10.1097\/MD.0000000000005769","journal-title":"Med"},{"key":"8751_CR75","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/myc.12636","volume":"60","author":"RN Wickramasekaran","year":"2017","unstructured":"Wickramasekaran RN, Jewell MP, Sorvillo F, Kuo T (2017) The changing trends and profile of pneumocystosis mortality in the United States, 1999\u20132014. Mycoses 60:607\u2013615","journal-title":"Mycoses"},{"key":"8751_CR76","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.gendis.2015.02.008","volume":"2","author":"IC Withrock","year":"2015","unstructured":"Withrock IC, Anderson SJ, Jefferson MA, McCormack GR, Mlynarczyk GSA, Nakama A, Lange JK, Berg CA, Acharya S, Stock ML, Lind MS, Luna KC, Kondru NC, Manne S, Patel BB, de la Rosa BM, Huang KP, Sharma S, Hu HZ, Kanuri SH, Carlson SA (2015) Genetic diseases conferring resistance to infectious diseases. Genes Dis 2:247\u2013254","journal-title":"Genes Dis"},{"key":"8751_CR77","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GIKH Wolfe","year":"2016","unstructured":"Wolfe GIKH, Aban IB, Minisman G et al (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375:511\u2013522","journal-title":"N Engl J Med"},{"key":"8751_CR78","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/imj.13371","volume":"47","author":"PKK Wong","year":"2017","unstructured":"Wong PKK, Bagga H, Barrett C, Hanrahan P, Johnson D, Katrib A, Leder K, Marabani M, Pentony P, Riordan J, White R, Young L (2017) A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia. Intern Med J 47:491\u2013500","journal-title":"Intern Med J"},{"key":"8751_CR79","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.0402391101","volume":"101","author":"N Yuki","year":"2004","unstructured":"Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain\u2013Barre syndrome. Proc Natl Acad Sci USA 101:11404\u201311409","journal-title":"Proc Natl Acad Sci USA"},{"key":"8751_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12979-016-0058-z","volume":"13","author":"M Zlamy","year":"2016","unstructured":"Zlamy M, Almanzar G, Parson W, Schmidt C, Leierer J, Weinberger B, Jeller V, Unsinn K, Eyrich M, Wurzner R, Prelog M (2016) Efforts of the human immune system to maintain the peripheral CD8+ T cell compartment after childhood thymectomy. Immun Ageing 13:3. https:\/\/doi.org\/10.1186\/s12979-016-0058-z","journal-title":"Immun Ageing"},{"key":"8751_CR81","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.1016\/j.vaccine.2010.10.002","volume":"28","author":"M Zlamy","year":"2010","unstructured":"Zlamy M, Wurzner R, Holzmann H, Brandstatter A, Jeller V, Zimmerhackl LB, Prelog M (2010) Antibody dynamics after tick-borne encephalitis and measles-mumps-rubella vaccination in children post early thymectomy. Vaccine 28:8053\u20138060","journal-title":"Vaccine"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-8751-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8751-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T18:45:47Z","timestamp":1719773147000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-8751-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["8751"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-8751-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"29 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"N.E. Gilhus has received speaker\u2019s honroraria from Octapharma, and honoraria for committee work from Argenx. There are no other conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}